Drug Profile
Anti-MRSA/VRSA sheep monoclonal antibody - KS Biomedix Holdings
Latest Information Update: 27 Sep 2002
Price :
$50
*
At a glance
- Originator KS Biomedix Holdings
- Class Monoclonal antibodies
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections
Most Recent Events
- 27 Sep 2002 Discontinued - Preclinical for Bacterial infections in United Kingdom (unspecified route)
- 18 Oct 2000 The product is available for licensing (http://www.ksbiomedix.com)
- 17 Dec 1997 Preclinical development for Bacterial infections in United Kingdom (Unknown route)